UNSPSC 51101638: Bialamicol

This classification denotes an antiprotozoal agent with the molecular formula C28H40N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TA5NM093QJ, chemically known as 5,5-diallyl-alpha,alpha-bis(diethylamino)-n,n-bitolyl-4,4-diol but generally known as bialamicol, which bears US NIH Compound Identifier 10304. Bialamicol most often comes in base and hydrochloride forms. European Medicines Agency schedules Bialamicol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05812MIG.

UNSPSC 51101638 Bialamicol is a Commodity code that in state and local procurement typically captures pharmaceutical active ingredients and chemical compounds used in drug formulation and manufacturing. Recent state and local opportunities tagged to this code, however, show minimal alignment with the nominal scope — the posted records reflect finished pharmaceutical products (antibiotics, naloxone) and drug deactivation systems rather than the raw chemical ingredient the code nominally describes. The Illinois Department of Public Health procured finished Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets through a piggyback cooperative purchasing vehicle, and Seminole County, Florida sought naloxone units and safe drug deactivation systems through an IFB. State agencies, county health departments, and special-purpose public health bodies appear to be the primary issuing parties under this code, though the specific tagging may reflect downstream pharmaceutical procurement rather than bialamicol-specific activity.

Geographic activity on recent records centers on Florida and Illinois. The Illinois Department of Public Health awarded a $2,999,999.11 contract to Chartwell Rx LLC on August 28, 2026 for pharmaceutical warehouse supply of Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets over 12 months with two renewal options; the award followed an IFB closed September 11, 2026. Seminole County posted an IFB on June 30, 2026 (due July 26, 2026) for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to its Community Health Building in Sanford. The code shows limited recent activity overall, and the opportunities present do not clearly demonstrate active state and local sourcing for bialamicol itself.